These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Platelet activating factor impairs pressor responses to noradrenaline in the anaesthetized rat but does not mediate endotoxin-induced hyporeactivity. Bouvier C, Guc MO, Furman BL, Parratt JR. Circ Shock; 1994 Jan; 42(1):14-9. PubMed ID: 8149505 [Abstract] [Full Text] [Related]
8. Pharmacological activities of a novel thienodiazepine derivative as a platelet-activating factor antagonist. Effects on microvascular permeability, hypotension and nephrosis. Sakuma Y, Shirato M, Nagaoka J, Obaishi H, Tsunoda H, Katayama S, Ono H, Katayama K. Arzneimittelforschung; 1991 Dec; 41(12):1255-9. PubMed ID: 1815526 [Abstract] [Full Text] [Related]
13. Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF). Merlos M, Giral M, Balsa D, Ferrando R, Queralt M, Puigdemont A, García-Rafanell J, Forn J. J Pharmacol Exp Ther; 1997 Jan; 280(1):114-21. PubMed ID: 8996188 [Abstract] [Full Text] [Related]
18. Effect of the platelet activating factor antagonist (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride on endotoxin-induced hypotension and hematological parameters in rats. Natsume Y, Imanishi N, Koike H, Morooka S. Arzneimittelforschung; 1994 Nov; 44(11):1208-13. PubMed ID: 7848333 [Abstract] [Full Text] [Related]
19. Comparative hemodynamics and cardiovascular effects of endotoxin and platelet-activating factor in rat. Salari H, Demos M, Wong A. Circ Shock; 1990 Nov; 32(3):189-207. PubMed ID: 2261677 [Abstract] [Full Text] [Related]